A new study supports the notion that the same mechanisms that help folks lose weight with Ozempic and its kin also work to ...

A long-acting GIP/GLP-1 receptor agonist conferred significant clinical benefit for people with obesity and accompanying ...

Some GLP-1 receptor agonists may hold promise as treatments for alcohol use disorder (AUD), a Swedish observational study ...

There have been a slew of studies recently supporting the notion that the same mechanisms that help folks lose weight ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

HERSHEY, PA. — GLP-1 weight-loss drugs are having a “mild impact” on The Hershey Co.’s business, president and chief ...

In addition to ensuring equitable access to the glucagon-like peptide-1 (GLP-1) receptor agonists, the medical community ...

Ozempic, Wegovy and other GLP-1 drugs have been shown to curb alcoholism, a new study suggests. Researchers explain why ...

opioid addiction Weight-loss drugs can help stroke survivors prevent recurrence Weight-loss surgeries decline 25% as GLP-1 drugs grow in popularity The diabetes meds in question are called GLP-1 ...

The key findings: In one main study, the medication exenatide did not significantly ... problems and lower alcohol use in people taking GLP-1 RAs compared to other treatments.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

about 44% of who were taking a GLP-1 medication. They tracked whether use of a GLP-1 med altered rates of alcohol use, alcohol-related health problems, hospital visits and "brain reactions to ...